Agarwal, A.
Leslie, W. D.
Nguyen, T. V.
Morin, S. N.
Lix, L. M.
Eisman, J. A.
Article History
Received: 8 October 2021
Accepted: 23 November 2021
First Online: 28 November 2021
Declarations
:
: The study was approved by the Health Research Ethics Board for the University of Manitoba.
: AA Agarwal, WD Leslie, LM Lix and SN Morin declare they have no conflict of interest. JA Eisman has consulted for and/or received research funding from Amgen, deCode, Merck Sharp and Dohme and Sanofi-Aventis. TV Nguyen has received honoraria for consulting and symposia from Merck Sharp and Dohme, Roche, Servier, Sanofi-Aventis and Novartis.